Surgery of the future: first operation with da Vinci Xi

MD Medical Group IPJSC ("MD Medical", "Group" or the "Company"; MOEX: MDMG), a leading Russian private healthcare provider, announces that it has completed its first ground-breaking robotic surgery.

The Lapino clinical hospital has performed its first operation using the cutting-edge da Vinci Xi surgical robot. Having undergone a successful radical prostatectomy, the patient is now recovering well.

As a fourth-generation system, da Vinci Xi is the most advanced surgical robot available in Russia. This sophisticated technology is unparalleled among major private healthcare providers in Moscow and the Moscow Region. Thanks to this high-tech assistant, surgeons can tackle complex procedures with minimal invasion and greater accuracy.

The robot features:

• high-precision 3D visualisation offering surgeons a three-dimensional view with tenfold magnification;

• responsive instruments – following the surgeon’s hand movements with micrometre precision, these tools bend and rotate beyond human capability to protect vessels, nerves, and organ function;

• mobile design, which gives surgeons access to any part of the body from any angle.

For patients, these advances deliver meaningful benefits:

• smaller incisions;

• reduced pain;

• minimal blood loss;

• lower complication risk;

• faster recovery and earlier discharge from hospital;

• reduced recurrence rates in cancer cases.

The da Vinci Xi system unlocks new possibilities across gynaecology, urology, thoracic, general, and cardiac surgery. It is particularly valuable for the surgical treatment of oncological diseases.

With the introduction of this robot, MD Medical Group begins a new chapter in delivering world-class medical care. Patients throughout our network have now access to this pinnacle of innovation.

About MD Medical Group

MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. Today, the Company manages 66 state-of-the-art healthcare facilities, including 11 multidisciplinary hospitals and 55 out-patient clinics in 31 regions of the Russian Federation. In 2024, MD Medical Group's revenue amounted to RUB 33.1 bln while EBITDA stood at RUB 10.7 bln. The Company's ordinary shares are traded on Moscow Exchange (MOEX: MDMG).